Showing 17,181 - 17,200 results of 60,818 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((ng decrease) OR (a decrease)) ))', query time: 1.16s Refine Results
  1. 17181
  2. 17182

    RAINFALL REGIME ON FINE ROOT GROWTH IN A SEASONALLY DRY TROPICAL FOREST by EUNICE MAIA DE ANDRADE (4894216)

    Published 2021
    “…The fine root biomass in July 2015 was 7.7±5.0 Mg ha-1 and the length was 5.0±3.2 km m-2. Fine root growth in SDTF is strongly limited by dry periods, occurring decreases in biomass and length of fine roots in all layers evaluated. …”
  3. 17183
  4. 17184
  5. 17185
  6. 17186
  7. 17187
  8. 17188
  9. 17189
  10. 17190

    Cilostazol attenuates intimal hyperplasia in a mouse model of chronic kidney disease by Wiwat Chancharoenthana (4662685)

    Published 2017
    “…At 20 weeks, cilostazol significantly attenuated aortic IH as demonstrated by a 34% reduction in the total intima area with 50% and 47% decreases in the ratios of tunica intima area/tunica media area and tunica intima area/(tunica intima + tunica media area), respectively. …”
  11. 17191

    A high seroprevalence of antibodies to pertussis toxin among Japanese adults: Qualitative and quantitative analyses by Takumi Moriuchi (4237807)

    Published 2017
    “…Positive correlations were observed between the titers of PT-neutralizing antibodies and anti-PT IgG in all age groups (r<sub>s</sub> values of 0.326–0.522), although the correlation tended to decrease with age. The ratio of PT-neutralizing antibodies to anti-PT IgG was significantly different when we compared the serum and purified IgG fractions among adults (<i>p</i> = 0.016), although this result was not observed among young and older children. …”
  12. 17192

    DataSheet_1_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…Background<p>Effective and safe vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are critical to controlling the COVID-19 pandemic and will remain the most important tool in limiting the spread of the virus long after the pandemic is over.…”
  13. 17193

    Table_3_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…Background<p>Effective and safe vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are critical to controlling the COVID-19 pandemic and will remain the most important tool in limiting the spread of the virus long after the pandemic is over.…”
  14. 17194

    Table_2_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…Background<p>Effective and safe vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are critical to controlling the COVID-19 pandemic and will remain the most important tool in limiting the spread of the virus long after the pandemic is over.…”
  15. 17195

    Table_4_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…Background<p>Effective and safe vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are critical to controlling the COVID-19 pandemic and will remain the most important tool in limiting the spread of the virus long after the pandemic is over.…”
  16. 17196

    Table_1_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…Background<p>Effective and safe vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are critical to controlling the COVID-19 pandemic and will remain the most important tool in limiting the spread of the virus long after the pandemic is over.…”
  17. 17197

    Winter Conditions and Land Cover Structure the Subnivium, A Seasonal Refuge beneath the Snow by Sonia K. Petty (746990)

    Published 2015
    “…To explore the effects of land cover and climate change on the subnivium, we measured snow pack characteristics (depth and density), and ambient and subnivium temperatures from three different land cover types (prairie, deciduous forest, and coniferous forest) and within a micro-greenhouse (2.5 x 2.5 x 2 m) that maintained a temperature of 5°C warmer than outdoor ambient temperatures, and automatically opened during snow events throughout the winter of 2013/14. …”
  18. 17198
  19. 17199

    Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-co... by Tadao Akizawa (316095)

    Published 2018
    “…Adverse events were observed in 30%–50% of patients (all groups). Incidence of adverse events was similar among all groups except for decreased calcium, which occurred more frequently in the evocalcet 2 mg and cinacalcet groups.…”
  20. 17200

    Data Sheet 1_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Evidence supports the use of TXL plus WM for reducing angina frequency [SMD −2.50, 95% CI (−3.53, −1.48)], improving seattle angina questionnaire scores (P < 0.05), decreasing nitroglycerin dose [SMD −1.63, 95% CI (−2.26, −1.00)], and shortening angina duration [MD −1.50 min/once, 95% CI (−1.98, −1.02)]. …”